| Medical and Health Sciences | 2021-2025 | 716 | GB 68 | 99.84 |
| Medical Biochemistry | Lifetime | 29 | GB 3 | 99.37 |
| Critical Care and Intensive Care Medicine | Lifetime | 56 | GB 3 | 98.79 |
| Hematology | Lifetime | 267 | GB 17 | 98.50 |
| Management of Technology and Innovation | Lifetime | 468 | GB 60 | 97.22 |
| Emergency Medicine | Lifetime | 775 | GB 66 | 91.42 |
| Medical Genetics | Lifetime | 846 | GB 59 | 89.42 |
| Medical Biochemistry | 2021-2025 | 8 | GB 1 | 98.72 |
| Hematology | 2021-2025 | 97 | GB 8 | 97.93 |
| Critical Care and Intensive Care Medicine | 2021-2025 | 67 | GB 5 | 94.41 |
| Blood transfusion and management | Lifetime | 5 | GB 1 | 99.71 |
| Blood donation and transfusion practices | Lifetime | 4 | GB 1 | 99.55 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 18 | GB 3 | 99.63 |
| Blood groups and transfusion | Lifetime | 48 | GB 6 | 99.28 |
| Platelet Disorders and Treatments | Lifetime | 103 | GB 9 | 99.05 |
| Hemoglobinopathies and Related Disorders | Lifetime | 149 | GB 15 | 98.73 |
| Neonatal Health and Biochemistry | Lifetime | 109 | GB 5 | 98.55 |
| Trauma and Emergency Care Studies | Lifetime | 151 | GB 13 | 99.02 |
| Blood disorders and treatments | Lifetime | 143 | GB 12 | 98.02 |
| Abdominal Trauma and Injuries | Lifetime | 113 | GB 9 | 98.22 |
| Neutropenia and Cancer Infections | Lifetime | 208 | GB 10 | 97.91 |
| Sepsis Diagnosis and Treatment | Lifetime | 875 | GB 50 | 96.62 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 937 | GB 57 | 96.67 |
| Iron Metabolism and Disorders | Lifetime | 812 | GB 72 | 95.84 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 570 | GB 59 | 93.85 |
| Erythropoietin and Anemia Treatment | Lifetime | 885 | GB 58 | 89.26 |
| Hemostasis and retained surgical items | Lifetime | 375 | GB 20 | 87.30 |
| Blood transfusion and management | 2021-2025 | 1 | GB 1 | 99.87 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 6 | GB 2 | 99.29 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 36 | GB 2 | 98.27 |
| Platelet Disorders and Treatments | 2021-2025 | 47 | GB 7 | 97.74 |
| Blood groups and transfusion | 2021-2025 | 41 | GB 5 | 97.40 |
| Blood disorders and treatments | 2021-2025 | 31 | GB 2 | 96.10 |
| Trauma and Emergency Care Studies | 2021-2025 | 211 | GB 16 | 95.32 |
| Iron Metabolism and Disorders | 2021-2025 | 133 | GB 16 | 94.72 |
| Neutropenia and Cancer Infections | 2021-2025 | 88 | GB 2 | 93.25 |
| Abdominal Trauma and Injuries | 2021-2025 | 71 | GB 6 | 91.29 |
| Neonatal Health and Biochemistry | 2021-2025 | 124 | GB 1 | 88.50 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 165 | GB 20 | 86.57 |
| Blood donation and transfusion practices | 2021-2025 | 140 | GB 9 | 86.97 |
| Clinical practice guidelines implementation | 2021-2025 | 294 | GB 32 | 82.83 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 266 | GB 23 | 77.66 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 701 | GB 27 | 73.13 |
| Hematological disorders and diagnostics | 2021-2025 | 969 | GB 37 | 47.84 |